What happened
G2Gbio updated the terms of convertible bonds to raise US$51.3M, about 10.5% of its market value.
For context, this raise equals about 10.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$51.3M |
| vs. market value | 10.5% |
| Filed | 2026-03-05, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260305001333 → open original filing |
Versions of this filing
- 2026-02-23Original
- 2026-03-05Amendment 1 (this page)
Source: DART. Information only, not investment advice.